control

Fibronectin is a high-molecular weight (~440kDa) extracellular matrix glycoprotein that binds to membrane-spanning receptor proteins called integrins.In addition to integrins, fibronectin also binds extracellular matrix components such as collagen, fibrin

SLLK, Control Peptide for TSP1 Inhibitor acetate is a control peptide for LSKL.

The compound is a negative control peptide for the Bax inhibitor peptides V5 and P5.

MPSDcontrol peptide (MARCKS-ED control peptide) TFA serves as the control peptide for MPSD. MPSD (MARCKS-ED) is a 25-amino acid peptide derived from the effector domain sequence of MARCKS, a myristoylated alanine-rich C kinase substrate, which is an intracellular membrane protein.

MPSDcontrol peptide (MARCKS-ED control peptide) serves as the counterpart for the MPSD peptide. MPSD (MARCKS-ED) is a 25-amino acid residue peptide derived from the effector domain sequence of the endoplasmic reticulum protein MARCKS. It can detect membrane curvature and identify phosphatidylserine, functioning as a biological probe for examining membrane morphology and lipid composition.

Fibronectin Active Fragment Control acetate is an active fragment of fibronectin which is a glycoprotein.

SLLK is a control peptide for LSKL.

Compstatin control peptide acetate is a negative control of Compstatin. Compstatin is an inhibitor of complement protein C3 by binding and inhibiting the cleavage of complement C3.

SN50M (NF-κB Control) is a synthetic peptide containing a hydrophobic region and a mutant nuclear localization sequence that enters cells but does not inhibit NF-κB nuclear translocation or induce apoptosis.

Tat-peptide 168-189, a cell-permeable, Tat-labeled fusion peptide derived from residues 168-189 of rat G3BP1, features the HIV Tat sequence at its least conserved terminus to enhance cellular uptake. It serves as the negative control for Tat-peptide 168-189 TFA, which promotes axon growth and neurite proliferation [1].

Rac1 Inhibitor F56, control peptide acetate is a control peptide version of Rac1 Inhibitor; comprises residues 45-60 of Rac1 with Trp56 replaced by Phe. Does not affect GEF-Rac1 interaction.

SLLK, the control peptide for the TSP1 inhibitor, serves as the counterpart to LSKL.

SjDX5-53 control peptide serves as a control for the TLR2 activator SjDX5-53, without targeting specific receptors or influencing regulatory T cells (Tregs) or dendritic cells. It is useful for excluding nonspecific effects and confirming SjDX5-53’s specific role in Tregs induction and autoimmune disease mitigation. This peptide is applied in research on autoimmune diseases like colitis and psoriasis.

ELA-14 negative control is an inactive peptide that serves as a negative control for ELA-14.

SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.

Control peptide version of dynamin inhibitory peptide, myristoylated, an inhibitor of the GTPase dynamin that competitively blocks binding of dynamin to amphiphysin, preventing endocytosis. In contrast to dynamin inhibitory peptide, has no significant eff

Control peptide version of Rac1 Inhibitor; comprises residues 45-60 of Rac1 with Trp56 replaced by Phe. Does not affect GEF-Rac1 interaction.

Tirzepatide (LY3298176) Acetate (2023788-19-2 free base) is a new molecule that can control blood glucose levels by combining dual agonism of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.[3]

ZIP (SCRAMBLED) Acetate (ZIP (SCRAMBLED) Acetate (908012-18-0 Free Base)) is a scrambled peptide that can be used as a negative control for zeta inhibitory peptide (ZIP).

RLLFT-NH2 acetate is a reversed amino acid sequence negative control peptide for TFLLR-NH2.

Arg-Gly-Glu-Ser acetate is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets.

PAMP-12 (human, porcine) acetate (PAMP-12 (human, porcine) acetate (196305-05-2 free base)) , a major component of ir-PAMP, is processed from the AM precursor, as is PAMP-20, and may participate in cardiovascular control.

Neurotensin TFA (39379-15-2 free base) is an endogenous 13 amino acid neuropeptide with profound opioid-independent analgesic effects. It behaves as a neurotransmitter in the brain, as a hormone in the gut, and also as a neuromodulator. It is implicated in the pathophysiology of several CNS disorders (including schizophrenia, Parkinson's disease, drug abuse, pain, cancer, inflammation, eating disorders, and central control of blood pressure) due to its association with a wide variety of neurotransmitter systems such as dopaminergic, sertonergic, glutamatergic, GABAergic, and cholinergic systems. It has a role as a human metabolite, a mitogen, a neurotransmitter and a vulnerary.

Indoleacetyl phenylalanine is an indole-3-acetyl-amino acid conjugate. It also involved in regulatory mechanisms for the control of auxin activity during physiological and pathophysiological responses.